The Clorox Company (NYSE:CLX) Shares Bought by Mitsubishi UFJ Asset Management Co. Ltd.

Mitsubishi UFJ Asset Management Co. Ltd. raised its holdings in The Clorox Company (NYSE:CLX - Free Report) by 5.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 229,291 shares of the company's stock after purchasing an additional 11,953 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. owned about 0.19% of Clorox worth $37,349,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Brooklyn Investment Group boosted its stake in Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company's stock valued at $25,000 after acquiring an additional 95 shares during the last quarter. Continuum Advisory LLC raised its stake in shares of Clorox by 300.0% in the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company's stock valued at $30,000 after purchasing an additional 138 shares in the last quarter. Millstone Evans Group LLC bought a new position in shares of Clorox during the fourth quarter worth about $31,000. Asset Planning Inc acquired a new position in Clorox in the fourth quarter worth about $32,000. Finally, Halbert Hargrove Global Advisors LLC bought a new stake in Clorox in the fourth quarter valued at about $36,000. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Stock Performance

Shares of CLX traded up $2.20 during mid-day trading on Thursday, reaching $149.82. 224,509 shares of the company's stock traded hands, compared to its average volume of 1,429,098. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The stock has a market capitalization of $18.46 billion, a P/E ratio of 40.93, a price-to-earnings-growth ratio of 2.62 and a beta of 0.45. The business's 50-day moving average price is $150.61 and its 200-day moving average price is $158.66.

Remove Ads

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the previous year, the business earned $2.16 earnings per share. Equities analysts predict that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be given a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, April 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.26%. Clorox's dividend payout ratio (DPR) is 133.33%.

Analyst Upgrades and Downgrades

CLX has been the subject of several research reports. JPMorgan Chase & Co. lifted their target price on Clorox from $171.00 to $173.00 and gave the stock a "neutral" rating in a research report on Tuesday, February 4th. Barclays decreased their price objective on shares of Clorox from $140.00 to $139.00 and set an "underweight" rating for the company in a report on Thursday, March 27th. Wells Fargo & Company dropped their target price on shares of Clorox from $161.00 to $155.00 and set an "equal weight" rating on the stock in a report on Wednesday. StockNews.com lowered shares of Clorox from a "buy" rating to a "hold" rating in a report on Sunday, January 5th. Finally, Evercore ISI increased their price objective on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Three investment analysts have rated the stock with a sell rating, ten have given a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, Clorox currently has an average rating of "Hold" and a consensus target price of $159.00.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.